
Estée Lauder Cos. raised its full-year sales and profit outlook on Monday after a first quarter in which fragrance sales climbed 20% on an organic basis and adjusted operating margin expanded to 12.1% from 7.3%. Shares of the New York-listed beauty group rose in early trading.
Net sales for the three months ended Sept. 30 rose 7% to $3.72 billion from $3.48 billion a year earlier. Organic sales, which strip out currency moves and acquisitions, grew 6%. Adjusted earnings per share came in at $0.72, up from $0.32, while reported diluted EPS rose to $0.64 from $0.13.
The company now expects fiscal 2027 adjusted EPS of $3.20 to $3.45, up from $3.10 to $3.35 set in August, implying growth of 28% to 38%. Organic sales growth guidance moved to 4% to 5.5% from 3% to 5%, and reported sales are now seen rising 5% to 6.5%. The adjusted operating margin target rose to 12.9% to 13.7% from 12.7% to 13.5%, and expected operating cash flow increased to $1.4 billion to $1.5 billion.
Fragrance was the strongest category, with net sales of $861 million and operating income nearly doubling to $166 million. Le Labo, Tom Ford, Jo Malone London and Kilian Paris led the gains. Skin care sales grew 5% to $1.65 billion, helped by La Mer and The Ordinary, and the category’s operating income rose 40% to $262 million.
Asia/Pacific was the fastest-growing region, with organic sales up 10% to $952 million and operating income up 73% to $259 million. Mainland China sales rose 15% on a reported basis and 9% organically to $614 million. The Americas grew 4% organically, as did the EUKEM segment.
Gross margin widened 230 basis points to 75.7%. Restructuring and other charges fell to $40 million from $89 million a year earlier.
Growth outside fragrance and skin care was thin. Makeup sales rose just 1% organically to $1.05 billion, with gains at M·A·C offset by a decline at the flagship Estée Lauder brand, and the category produced only $3 million of operating income on more than $1 billion of revenue. Hair care was flat organically, as supply chain logistics problems cut sales at Aveda.
Cash generation remains seasonal and negative in the first quarter. Operating cash flow was an outflow of $166 million and free cash flow an outflow of $235 million, although both improved from outflows of $340 million and $436 million a year earlier. The raised outlook assumes no deterioration in the geopolitical landscape, including tariffs, and the company gave no second-quarter guidance.
Part of the reported growth came from currency. Mainland China’s reported growth of 15% compared with organic growth of 9%, and the company expects foreign exchange to add about 1 percentage point to full-year reported sales while cutting about $0.04 from EPS.
A lower tax rate also lifted earnings. The effective tax rate fell to 32.5% from 56.9% a year earlier, and the adjusted rate dropped to 31.9% from 40.5%. Restructuring charges are now projected at $0.44 to $0.50 per share for the year, against $1.83 in fiscal 2026.
The guidance also includes accounting effects from the Oct. 5 purchase of the remaining stake in Mountain Valley Springs India, owner of the Forest Essentials Ayurvedic brand. The company expects a gain of $0.25 to $0.27 per share on its previously held equity interest, partly offset by a one-time inducement payment of $0.10.
Estée Lauder ended the quarter with $3.2 billion of cash, up from $2.22 billion a year earlier, against about $7.25 billion of total debt. Consumer-facing investment rose 8% from a year earlier. The board kept the quarterly dividend at $0.35 per share, payable Dec. 15 to holders of record on Nov. 30.
Sources: SEC, elcompanies.com, Yahoo Finance, Bloomberg.









